418 related articles for article (PubMed ID: 24035045)
21. Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials.
Hong Y; Mansour S; Alotaibi G; Wu C; McMurtry MS
Crit Rev Oncol Hematol; 2018 May; 125():12-18. PubMed ID: 29650271
[TBL] [Abstract][Full Text] [Related]
22. Treatment of venous thromboembolism.
Wells PS; Forgie MA; Rodger MA
JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
[TBL] [Abstract][Full Text] [Related]
23. Association between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study.
Méan M; Tritschler T; Limacher A; Breault S; Rodondi N; Aujesky D; Qanadli SD
PLoS One; 2017; 12(6):e0179224. PubMed ID: 28594950
[TBL] [Abstract][Full Text] [Related]
24. [Outpatient treatment of venous throemboembolic disease].
Otero Candelera R; Elías Hernández T; González Vergara D
Med Clin (Barc); 2009 Jul; 133(7):272-6. PubMed ID: 19386325
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
[TBL] [Abstract][Full Text] [Related]
26. Best Clinical Practice: Controversies in Outpatient Management of Acute Pulmonary Embolism.
Long B; Koyfman A
J Emerg Med; 2017 May; 52(5):668-679. PubMed ID: 28007362
[TBL] [Abstract][Full Text] [Related]
27. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
28. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
29. Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization: The Low-Risk Pulmonary Embolism Prospective Management Study.
Bledsoe JR; Woller SC; Stevens SM; Aston V; Patten R; Allen T; Horne BD; Dong L; Lloyd J; Snow G; Madsen T; Elliott CG
Chest; 2018 Aug; 154(2):249-256. PubMed ID: 29410163
[TBL] [Abstract][Full Text] [Related]
30. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
Huang W; Goldberg RJ; Cohen AT; Anderson FA; Kiefe CI; Gore JM; Spencer FA
Thromb Res; 2015 Jun; 135(6):1100-6. PubMed ID: 25921936
[TBL] [Abstract][Full Text] [Related]
31. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
32. The creation and implementation of an outpatient pulmonary embolism treatment protocol.
Kabrhel C; Rosovsky R; Baugh C; Parry BA; Deadmon E; Kreger C; Giordano N
Hosp Pract (1995); 2017 Aug; 45(3):123-129. PubMed ID: 28402686
[TBL] [Abstract][Full Text] [Related]
33. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
34. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.
Maestre A; Trujillo-Santos J; Riera-Mestre A; Jiménez D; Di Micco P; Bascuñana J; Vela JR; Peris L; Malfante PC; Monreal M;
Ann Am Thorac Soc; 2015 Aug; 12(8):1122-9. PubMed ID: 26114586
[TBL] [Abstract][Full Text] [Related]
35. Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials.
Mearns ES; Coleman CI; Patel D; Saulsberry WJ; Corman A; Li D; Hernandez AV; Kohn CG
J Thromb Haemost; 2015 Jun; 13(6):1043-52. PubMed ID: 25819920
[TBL] [Abstract][Full Text] [Related]
36. Thromboprophylaxis for trauma patients.
Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
[TBL] [Abstract][Full Text] [Related]
37. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
38. Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.
Lutsey PL; Walker RF; MacLehose RF; Norby FL; Evensen LH; Alonso A; Zakai NA
J Am Heart Assoc; 2021 Oct; 10(20):e020428. PubMed ID: 34622678
[TBL] [Abstract][Full Text] [Related]
39. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
[TBL] [Abstract][Full Text] [Related]
40. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
